
Virtual Substance Use Disorders: A Comprehensive Review and Update 2026
Overview
We invite you to join us Virtually for our Substance Use Disorders: A Comprehensive Review and Update 2026 Conference!
Please Note: The conference will be held in Eastern Daylight Time (EDT)
Attend this conference virtually on substance use disorders to hear the latest research and find guidance that enhances your care for patients.
Substance use disorders are complex and have a huge impact on patients, families, and communities They challenge even experienced health care professionals to stay current with evolving guidelines. They are seen and treated across all professions, disciplines, and practice settings. This includes primary care, psychiatry, social work, psychology, family practice, nursing and more.
That's why our agenda focuses on a broad update across the spectrum of substance use disorders. Sessions cover everything from neuroscience and developmental perspectives all the way through recovery-oriented systems of care. Our faculty share their experience as both clinical caregivers and research experts. They make time to answer questions and help you find solutions for complex conditions.
You will receive email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the Zoom instructions and attending virtually.
Pricing
MDs/Doctoral-Level Professionals:
Super Early Bird Registration (before October 14, 2025): $695
Early Bird Registration (before December 2, 2025): $795
Regular Registration (after December 2, 2025): $895
Other Professionals or Trainees:
Super Early Bird Registration (before October 14, 2025): $595
Early Bird Registration (before December 2, 2025): $695
Regular Registration (after December 2, 2025): $795
E-SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Cancellation Policy
A refund minus a $100.00 administrative fee will be issued for refund requests received by January 1, 2026. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition
Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.
Target Audience
This program is intended for:
- General and Family Physicians
- Psychiatrists
- Nurse Practitioners
- Physician Assistants
- Nurses
- Psychologists
- Social Workers
Learning Objectives
Please come back later for this information.
Accreditation:
Please come back later for this information.
Program
Substance Use Disorders: A Comprehensive Review and Update
February 6-7, 2026
FRIDAY, FEBRUARY 6, 2026
8:00 – 8:05 AM Welcome & Introduction
David H. Rubin, MD
MODULE TOPIC 1: NEUROSCIENCE
8:05 – 8:25 AM Neurobiology of Addiction & Genetics of Substance Use Disorders
Robert R. Althoff, MD, PhD
MODULE TOPIC 2: ADOLESCENT SUBSTANCE USE
8:25– 8:45 AM Adolescent Substance Use Disorders
Aaron Quiggle, MD
8:45 – 9:05 AM ADHD
Timothy Wilens, MD
9:05 – 9:25 AM Athletes and Substance Use Disorders
Timothy Wilens, MD
9:25 – 9:55 AM Panel Discussion
Moderator: David H. Rubin, MD
Panelists: Robert R. Althoff, MD, PhD, Timothy E. Wilens, MD;
Aaron Quiggle, MD
9:55 – 10:05 AM Break
MODULE TOPIC 3: ADVOCACY & BENZODIAZEPINES
10:05 – 10:25 AM Advocacy and Regulatory Updates
Laura G. Kehoe, MD, MPH, FASAM
10:25 – 10:45 AM Benzodiazepines & Addiction
Timothy Wilens, MD
10:45 – 11:15 AM Panel Discussion
Moderator: Timothy E. Wilens, MD
Panelists: Laura G. Kehoe, MD, MPH, FASAM
11:15 – 12:15 PM Lunch Break
MODULE TOPIC 4: OPIOIDS
12:15 – 12:35 PM Buprenorphine 101
Meredith Morrison, NP
12:35 – 12:55 PM Long Acting Injectable Buprenorphine
Laura Kehoe, MD, MPH, FASAM
12:55 – 1:15 PM Naltrexone Intramuscular
Jessica Gray, MD
1:15 – 1:35 PM Methadone
Laura Kehoe, MD, MPH, FASAM
1:35 – 1:45 PM Break
1:45 – 2:15 PM Panel Discussion
Moderator: Laura G. Kehoe, MD, MPH, FASAM
Panelist: Jessica Gray, MD, and Meredith Morrison, NP
MODULE TOPIC 5: PAIN, WOMEN & ADDICTION
2:15 – 2:35 PM Pain
TBA
2:35 – 2:55 PM Pregnancy
Jessica Gray, MD
2:55 – 3:15 PM Women & Addiction
Davida Schiff, MD
3:15 – 3:35 PM Panel Discussion
Moderator: Jessica Gray, MD
Panelists: Greg Acampora, MD; Davida Schiff, MD
4:25 PM Adjourn
SATURDAY, FEBRUARY 7, 2026
8:00 – 8:05 AM Welcome & Introduction
John Kelly, PhD
MODULE TOPIC 6: TREATMENT IN CONTINUING CARE
8:05 – 8:25 AM Motivational Interviewing
James McKowan, MD
8:25 – 8:45 AM CBT
James McKowan, MD
8:45 – 9:05 AM DBT & Other Therapies
James McKowan, MD
9:05 – 9:35 AM Panel Discussion
Moderator: John Kelly, PhD
Panelists: James McKowan, MD
9:35 – 9:45 AM Break
MODULE TOPIC 7: PSYCHEDELICS
9:45 – 10:05 AM Psychedelics
Joji Suzuki, MD
MODULE TOPIC 8: CANNABIS
10:05 – 10:25 AM Cannabis
Jodi Gilman, PhD
MODULE TOPIC 9: COMORBIDITY I – SUBSTANCE USE, TRAUMA AND SEX TRAFFICKING
10:25 – 10:45 AM Trauma
Toby Lynch, PhD
10:45 – 11:05 AM Sex Trafficking
Abigail Judge, PhD
11:05 – 11:35 AM Panel Discussion
Moderator: Justin Alves, RN, MSN, ACRN, CARN, CNE
Panelists: Abigail Judge, PhD; Toby Lynch, PhD; Jodi Gilman, PhD; Joji Suzuki, MD
11:35 – 12:35 PM Lunch Break
MODULE TOPIC 10: NICOTINE & STIMULANTS
12:35 – 12:55 PM Cocaine & Methamphetamine
Justin Alves, RN, MSN, ACRN, CARN, CNE
12:55 – 1:15 PM Nicotine
A. Eden Evins, MD
1:15 – 1:45 PM Panel Discussion
Moderator: John Kelly, PhD
Panelists: Justin Alves, RN, MSN, ACRN, CARN, CNE; A. Eden Evins, MD
MODULE TOPIC 11: RECOVERY SUPPORT SERVICES
1:45 – 2:05 PM Addressing and Overcoming Stigma & Discrimination in Clinical Settings
John Kelly, PhD
2:05 – 2:25 PM Peer Support and Residential Communities
David Eddie, PhD
2:25 – 2:45 PM Efficacy of Self-Help Treatments
John Kelly, PhD
2:45 – 3:05 PM Amplifying and Extending the Effects of Clinical Care
John Kelly, PhD
3:05 – 3:35 PM Panel Discussion
Moderator: John Kelly, PhD
Panelist: John Kelly, PhD; David Eddie, PhD
3:35 – 3:45 PM Break
MODULE TOPIC 12: ALCOHOL & COMORBIDITY
3:45 – 4:05 PM Alcohol: Assessment and Maintenance Medications
Vinod Rao, MD, PhD
4:05 – 4:25 PM Inpatient & Outpatient Medically Managed Withdrawal
Evan Gale, MD
4:25 – 4:45 PM Anxiety & Mood
Vinod Rao, MD, PhD
4:45 – 5:15 PM Panel Discussion
Moderator: Vinod Rao, MD, PhD
Panelist: Evan Gale, MD
5:15 PM Adjourn
Faculty
Please come back later for this information.